Market Value1,207,754,000
Total Holdings46
File Date2019-10-11
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
LXRX / Lexicon Pharmaceuticals, Inc.
SENS / Senseonics Holdings, Inc.
YMTX / Yumanity Therapeutics Inc
US29266S3040 / Endologix, Inc.
ARDX / Ardelyx, Inc.
SURF / Surface Oncology Inc
RARX / Ra Pharmaceuticals, Inc.
EYRYY / Erytech Pharma
LQDA / Liquidia Corporation
EPZM / Epizyme Inc
BE / Bloom Energy Corporation
DERM / Journey Medical Corporation
TRVN / Trevena, Inc.
/ Achaogen Inc
AFMD / Affimed N.V.
XENE / Xenon Pharmaceuticals Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
MEIP / MEI Pharma, Inc.
RIGL / Rigel Pharmaceuticals, Inc.
SBBP / Strongbridge Biopharma plc
TRIL / Trillium Therapeutics Inc
NET / Cloudflare, Inc.
DZSI / DZS Inc.
PHAS / PhaseBio Pharmaceuticals Inc
MRSN / Mersana Therapeutics, Inc.
GNCA / Genocea Biosciences Inc
RYTM / Rhythm Pharmaceuticals, Inc.
OBSV / ObsEva SA.
TCON / TRACON Pharmaceuticals, Inc.
VIRX / Viracta Therapeutics, Inc.
MRKR / Marker Therapeutics, Inc.
TPST / Tempest Therapeutics, Inc.
CTIC / CTI BioPharma Corp
AVEO / AVEO Pharmaceuticals Inc
TRVI / Trevi Therapeutics, Inc.
GLYC / GlycoMimetics, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
SYBX / Synlogic, Inc.
AUPH / Aurinia Pharmaceuticals Inc.
CSBR / Champions Oncology, Inc.
XFOR / X4 Pharmaceuticals, Inc.
CRSP / CRISPR Therapeutics AG
ALLK / Allakos Inc.
MIRM / Mirum Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
RGLS / Regulus Therapeutics Inc.